Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...
Knox Henderson | July 2, 2024 |

Hydrogen stocks with top news; Plug, Nucera and DynaCERT in focus

Despite negative quarterly figures, the Plug Power stock has developed positively in recent days. Is this the turnaround for the hydrogen pure play? The Americans recently reported progress on a mega-project. DynaCERT is strengthening its position with an industry ex...
Fabian Lorenz | May 22, 2024 |

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...
Knox Henderson | March 20, 2024 |

Medicus Pharma advances cancer treatment towards phase II trial

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Our next company is Medicus Pharma Ltd. (TSXV:MDCX) , headquartered in Philadelphia, Pennsylvania. The company is a publicly traded clinical stage, multi-st...
Ryan Dhillon | January 22, 2024 |

First Mining Gold: Advancing two of Canada's biggest gold projects

First Mining Gold is working to develop precious metal resources in Ontario and Quebec. The Vancouver-based gold developer is currently focused on advancing two of the largest gold projects in Canada. First Mining Gold Chief Executive Officer Daniel Wilton sat down ...
Simon Druker | May 4, 2023 |

Silvercorp Metals (TSX:SVM): Three Pillars for a Sound Silver Investment

By Dr. Ryan D. LongSilvercorp Metals (TSX:SVM, NYSE American: SVM, Forum) has established three pillars on which it expects to grow over the coming years. In previous reports, I have talked about...
Research | November 10, 2022 |

Calima Energy (ASX:CE1) reports record production for Q3 2022

Calima Energy (ASX:CE1) has achieved record production of 382,910 boe in Q3 2022.
Trevor Abes | November 3, 2022 |

Silvercorp's (TSX:SVM) investee advances Bolivian silver project towards late 2022 PEA

One does not need to be a geologist to spot the potential of New Pacific Metals' (TSX:NUAG) Silver Sand project in Bolivia.
Research | November 2, 2022 |

The World Economy Needs Copper!! Pan Global - A Major Spanish Copper Discovery

Pan Global Resources (TSXV:PGZ) is actively engaged in base and precious metal exploration in southern Spain.
Research | October 21, 2022 |

Canadian Fintech RevoluGROUP targeted in the heated M&A takedown

2022 has seen its fair share of mergers and acquisitions in the Fintech world. But the year isn’t over yet; there could be yet another, and this time it’s a Canadian Fintech. A little-known...
Research | October 19, 2022 |
1 2 3 4 5 6 7 8 9 10 ...